OnTheIssuesLogo

Richard Blumenthal on Drugs

 

 


Rated C by NORML, indicating a mixed record on drug reform.

Blumenthal scores C by the NORML on drug reform

OnTheIssues.org interprets the 2016 NORML scores as follows:

About NORML (from their website, www.norml.org):

National Organization for the Reform of Marijuana Law's mission is to move public opinion sufficiently to achieve the repeal of marijuana prohibition so that the responsible use of cannabis by adults is no longer subject to penalty.

NORML is a nonprofit, public-interest lobby that for more than 30 years has provided a voice for those Americans who oppose marijuana prohibition. We represent the interests of the tens of millions of Americans who smoke marijuana responsibly and believe the recreational and medicinal use of marijuana should no longer be a crime.

NORML supports the removal of all criminal penalties for the private possession & responsible use of marijuana by adults, including the cultivation for personal use, and the casual nonprofit transfers of small amounts. This model is called "decriminalization."

NORML additionally supports the development of a legally controlled market for marijuana, where consumers could purchase it from a safe, legal and regulated source. This model is referred to as "legalization."

NORML believes that marijuana smoking is not for kids and should only be used responsibly by adults. As with alcohol consumption, it must never be an excuse for misconduct or other bad behavior. Driving or operating heavy equipment while impaired from marijuana should be prohibited.

NORML strongly supports the right of patients to use marijuana as a medicine when their physician recommends it to relieve pain and suffering.

Lastly, NORML supports the right of farmers to commercially cultivate hemp for industrial purposes, such as food and fiber production.

Source: NORML website 16_NORML on Nov 8, 2016

Criminalize imports of opioid precursors.

Blumenthal signed criminalizing imports of opioid precursors

Excerpts from Letter from 17 Senators to the President of the European Commission We write to request designating NPP and ANPP, which are precursor chemicals of the synthetic opioid fentanyl, as Table I substances under the 1988 UN Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances. NPP and ANPP are [legal under EU law but] already controlled in the U.S. under the Controlled Substances Act. However, without collective international action it will be difficult to control NPP and ANPP, and will frustrate efforts to curb manufacturing and trafficking of illicit fentanyl.

Opposing argument: (ACLU, "Against Drug Prohibition"): People in almost all cultures, in every era, have used psychoactive drugs. A "drug free America" is not a realistic goal, and by criminally banning psychoactive drugs the government has ceded control of potentially dangerous substances to criminals. Instead of trying to stamp out drug use, our government should focus on reducing drug abuse and prohibition-generated crime. This requires a fundamental change in public policy: repeal of criminal prohibition and the creation of a reasonable regulatory system.

Opposing argument: (Cato Institute, "Do Restrictions Reduce Opioid Poisonings?", by Jeffrey Miron): Prescription Drug Monitoring Programs (PDMPs), which record a patient's opioid prescribing history, when required as "must access," PDMPs significantly reduce misuse in Medicare Part D. But there is no statistically significant effect on opioid poisoning incidents. How is this possible? The simplest explanation is that, despite all the hype, prescription opioids are not that dangerous, even in heavy doses, when used under medical supervision. Instead, most poisonings reflect use of diverted prescription opioids, or black market opioids, which may be adulterated. Under this interpretation, restrictions on opioid prescribing might even increase opioid poisonings.

Source: Letter on Fentanyl 17LTR-NPP on Feb 17, 2017

Other candidates on Drugs: Richard Blumenthal on other issues:
CT Gubernatorial:
Dan Malloy
Danny Drew
David Walker
Larry Kudlow
Linda McMahon
Prasad Srinivasan
Tom Foley
CT Senatorial:
Chris Murphy

CT politicians
CT Archives

Retiring in 2014 election:
GA:Chambliss(R)
IA:Harkin(D)
MI:Levin(D)
MT:Baucus(D)
NE:Johanns(R)
SD:Johnson(D)
WV:Rockefeller(D)

Retired as of Jan. 2013:
AZ:Kyl(R)
CT:Lieberman(D)
HI:Akaka(D)
ND:Conrad(D)
NM:Bingaman(D)
TX:Hutchison(R)
VA:Webb(D)
WI:Kohl(D)
Senate races 2017-8:
AL: Strange(R) ; no opponent yet
AZ: Flake(R) vs. Ward(R)
CA: Feinstein(D) vs. Eisen(D) vs. Sanchez?(D) vs. Garcetti?(D)
CT: Murphy(D) ; no opponent yet
DE: Carper(D) vs. Biden?(D) vs. Markell?(D)
FL: Nelson(D) vs. DeSantis(R) vs. Jolly(R) vs. Lopez-Cantera(R)
HI: Hirono(D) ; no opponent yet
IN: Donnelly(D) vs. Hurt(R)
MA: Warren(D) vs. Ayyadurai(R)
MD: Cardin(D) ; no opponent yet
ME: King(I) vs. LePage?(R)
MI: Stabenow(D) vs. Bouchard?(R)
MN: Klobuchar(D) vs. Paulsen?(R)
MO: McCaskill(D) vs. Kinder?(R)
MS: Wicker(R) vs. McDaniel?(R)
MT: Tester(D) vs. Racicot?(R)

ND: Heitkamp(D) vs. Becker?(R)
NE: Fischer(R) ; no opponent yet
NJ: Menendez(D) vs. Chiesa(R) vs. Codey?(D) vs. Chiesa?(R)
NM: Heinrich(D) vs. Sanchez(R)
NV: Heller(R) vs. Sandoval?(R)
NY: Gillibrand(D) vs. Kennedy?(D)
OH: Brown(D) vs. Mandel(R)
PA: Casey(D) vs. Saccone(R)
RI: Whitehouse(D) ; no opponent yet
TN: Corker(R) vs. Crim(I)
TX: Cruz(R) vs. Bush?(R)
UT: Hatch(R) vs. McMullin?(R) vs. Romney?(R)
VT: Sanders(I) vs. Giordano(D)
VA: Kaine(D) vs. Cuccinelli?(R) vs. Fiorina?(R)
WA: Cantwell(D) ; no opponent yet
WV: Manchin(D) vs. Raese(R) vs. Goodwin?(R)
WI: Baldwin(D) vs. Grothman?(R) vs. Gallagher?(R)
WY: Barrasso(R) ; no opponent yet
Abortion
Budget/Economy
Civil Rights
Corporations
Crime
Drugs
Education
Energy/Oil
Environment
Families
Foreign Policy
Free Trade
Govt. Reform
Gun Control
Health Care
Homeland Security
Immigration
Jobs
Principles
Social Security
Tax Reform
Technology
War/Peace
Welfare

Other Senators
Senate Votes (analysis)
Bill Sponsorships
Affiliations
Policy Reports
Group Ratings
 
Search for...





Page last updated: Sep 03, 2017